Dermaseptin S4 (1-22)
General Information
DRACP ID DRACP02904
Peptide Name Dermaseptin S4 (1-22)
Sequence ALWMTLLKKVLKAAAKAALNAV
Sequence Length 22
UniProt ID P80280
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
SW620 | Colon adenocarcinoma | Carcinoma | 66.21±20.07% Cytotoxicity=256 µg/ml | MTT assay | 3h | 1 |
Hemolytic Activity Human erythrocytes: 80±1.12% Hemolysis=256 µg/ml
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C109H190N28O25S
Absent amino acids CDEFGHIPQRSY
Common amino acids A
Mass 269974
Pl 11.28
Basic residues 4
Acidic residues 0
Hydrophobic residues 15
Net charge 4
Boman Index 1862
Hydrophobicity 96.36
Aliphatic Index 146.82
Half Life
Mammalian: 4.4 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 5500
Absorbance 280nm 261.9
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 33774792
Title Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620
Doi 10.1007/s11356-021-13683-2 Abstract
Year 2021
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_18032